Molnunat Molnupiravir 200
Price range: $70.00 through $210.00
| Quantity Value | Price | Quantity | Add To Cart |
|---|---|---|---|
| 160 Capsules | $210.00 |
|
|
| 40 Capsules | $70.00 |
|
|
| 80 Capsules | $115.00 |
|
SKU : N/A
Category : Viral Care
Molnunat Molnupiravir 200 mg is an oral antiviral medicine prescribed for treating mild to moderate COVID-19 in adults at risk of severe illness. It works by interfering with the replication of the SARS-CoV-2 virus to help reduce viral load and disease severity when started early.
Molnunat Molnupiravir 200 mg
Molnunat Molnupiravir 200 mg is an antiviral medication used in the treatment of mild to moderate COVID-19 infection in adults who are at risk of progressing to severe disease, hospitalization, or death. Its active ingredient, molnupiravir, belongs to a class of antivirals known as nucleoside analogues that work by targeting the viral replication process. This medicine is administered orally in capsule form and is most effective when taken early in the course of infection — ideally within the first five days of symptom onset.
Mechanism of Action
Molnupiravir is a prodrug — an inactive compound that is metabolized in the body into its active form. Once absorbed, it is converted into N-hydroxycytidine (NHC), a nucleoside analogue that mimics one of the building blocks of viral genetic material. The active form is then incorporated by the enzyme RNA-dependent RNA polymerase (RdRp) into the SARS-CoV-2 viral RNA during replication. This incorporation introduces a high number of mutations into the viral genome, leading to what is termed “error catastrophe,” which ultimately produces non-viable viral progeny and reduces the virus’s ability to multiply and spread.
Primary Uses and Indications
Molnunat Molnupiravir 200 mg is specifically indicated for the oral treatment of mild to moderate COVID-19 in adults who:
-
Have tested positive for the SARS-CoV-2 virus and
-
Are at high risk of progression to severe illness or complications due to age or underlying conditions like diabetes, heart disease, or compromised immunity.
It is important to note that this medicine is not recommended for COVID-19 prevention (prophylaxis) and is not suitable for hospitalized patients with severe disease.
Dosage and Administration
The typical treatment regimen for Molnunat Molnupiravir 200 mg involves:
-
800 mg per dose (equivalent to four 200 mg capsules)
-
Taken twice daily (every 12 hours)
-
For a total treatment course of 5 days
The capsules should be swallowed whole with water and may be taken with or without food. It is critical to complete the full prescribed course, even if symptoms improve before the treatment period ends.
Benefits of Treatment
When used appropriately — particularly within the first five days of symptom onset — Molnunat Molnupiravir 200 mg may:
-
Reduce the viral load in the body, helping the immune system control the infection
-
Lower the risk of disease progression to severe COVID-19
-
Decrease the likelihood of hospitalization or death in high-risk adults
As an oral antiviral, it offers the convenience of at-home treatment compared to intravenous drug options, allowing earlier intervention outside hospital settings.
Possible Side Effects
Although many patients tolerate molnupiravir well, some may experience side effects during treatment. Commonly reported reactions include:
-
Nausea
-
Diarrhea
-
Headache
-
Dizziness
These side effects are usually mild and temporary. Severe reactions are uncommon but should be discussed with a healthcare provider if they occur.
Precautions and Contraindications
Certain precautions should be taken when using Molnunat Molnupiravir 200 mg:
-
Pregnancy and breastfeeding: The drug is not recommended during pregnancy due to potential risks to the fetus, and women of childbearing potential should use effective contraception during treatment and for a short period afterward.
-
Allergic reactions: Patients known to be allergic to molnupiravir or any capsule components should avoid this medicine.
-
Children: It is generally not recommended for individuals under 18 years due to lack of safety data in pediatric populations.
Healthcare providers should be informed of all underlying health conditions and concomitant medications to prevent interactions or complications.
Storage Instructions
Molnunat should be stored in a cool, dry place away from direct sunlight, moisture, and heat. Keep the capsules out of reach of children and pets.
External Link for More Information
For trusted and detailed medical information about molnupiravir and its use in COVID-19 treatment, you can visit the U.S. National Library of Medicine’s entry on molnupiravir:
https://www.ncbi.nlm.nih.gov/books/NBK574519/
| Pack Size |
160 Capsules ,40 Capsules ,80 Capsules |
|---|
Related products
Artecan 120 mg Injection
Artecan 120 mg Injection is a potent antimalarial medicine containing artesunate used to treat severe malaria caused by Plasmodium falciparum. It works rapidly to reduce parasite load and improve clinical outcomes when administered by a healthcare professional. (WHO – Malaria Treatment Guidelines)
